Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Business Daily.
Press releases published on November 5, 2025
November 5, 2025
SiTime Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 5, 2025
Coherent Corp. Reports First Quarter Fiscal 2026 Results
Indeterminate
GlobeNewswire
November 5, 2025
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
Indeterminate
GlobeNewswire
November 5, 2025
Latham Group, Inc. to Participate at the Upcoming Baird 2025 Global Industrial Conference
Indeterminate
GlobeNewswire
November 5, 2025
Sprout Social Announces Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment
Indeterminate
GlobeNewswire
November 5, 2025
Veeco Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
Surrozen to Present at Upcoming Healthcare Investor Conference
Indeterminate
GlobeNewswire
November 5, 2025
Generation Bio Announces Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
CVRx Reports Third Quarter 2025 Financial and Operating Results
Indeterminate
GlobeNewswire
November 5, 2025
Interparfums, Inc. Reports 2025 Third Quarter Results
Indeterminate
GlobeNewswire
November 5, 2025
AMSC Reports Second Quarter Fiscal Year 2025 Financial Results and Business Outlook
Indeterminate
GlobeNewswire
November 5, 2025
Lightbridge Provides Business Update and Announces Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2025
Indeterminate
GlobeNewswire
November 5, 2025
Lantronix Reports Fiscal First Quarter 2026 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire